Bain Capital Life Sciences Investors, LLC, 10% Owner at MARINUS PHARMACEUTICALS INC (MRNS), sold 2,245,094 shares at $8.02 ($17.8M) on 2017-12-15, disclosed to the SEC on 2017-12-19.
Open-market sale of $17.8M MRNS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.02 | 719,665 | $5.8M | 32.4% |
| 2 | $8.02 | 719,665 | $5.8M | 32.4% |
| 3 | $8.64 | 102,882 | $889K | 5.0% |
| 4 | $8.64 | 102,882 | $889K | 5.0% |
| 5 | $7.50 | 300,000 | $2.3M | 12.6% |
| 6 | $7.11 | 55,229 |
| $393K |
| 2.2% |
| 7 | $7.11 | 55,229 | $393K | 2.2% |
| 8 | $7.62 | 94,771 | $722K | 4.1% |
| 9 | $7.62 | 94,771 | $722K | 4.1% |
| Total | $7.93 avg | 2,245,094 | $17.8M | 100% |
| Filing → |
| HTFL | SELL | 2026-02-06 | $56.1M | — | Filing → |
| OLMA | BUY | 2025-01-13 | $1.7M | — | Filing → |
| ANNX | BUY | 2023-05-30 | $639K | — | Filing → |